Michihiro Mutoh
Impact in
- Cancer Research top 2%
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Pharmacology top 0.5%
- Inflammatory mediators and NSAID effects
Papers in
-
- Cancer, Lipids, and Metabolism 24
- Pharmacology 34
- Inflammatory mediators and NSAID effects 29
- Co-authors
- Mami TakahashiKeiji WakabayashiTakashi SügimuraToshihiko KawamoriKazunori FukudaI BaeJoany JackmanDominic A. Scudiero
- Journals
- Cancer Science (14 papers)Journal of Clinical Biochemistry and Nutrition (10 papers)Carcinogenesis (10 papers)Genes and Environment (6 papers)International Journal of Molecular Sciences (5 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Michihiro Mutoh
161 papers receiving 4.6k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Cancer Research 954
- Pharmacology 937
- Oncology 1.4k
- Biotechnology 278
- Biochemistry 191
Countries citing papers authored by Michihiro Mutoh
This map shows the geographic impact of Michihiro Mutoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michihiro Mutoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michihiro Mutoh more than expected).
Fields of papers citing papers by Michihiro Mutoh
This network shows the impact of papers produced by Michihiro Mutoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michihiro Mutoh. The network helps show where Michihiro Mutoh may publish in the future.
Co-authors
The 25 scholars most cited alongside Michihiro Mutoh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 3 | |
| 7 | 2022 | 1 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 1 | |
| 10 | 2022 | 21 | |
| 11 | 2021 | 8 | |
| 12 | 2021 | 13 | |
| 13 | 2021 | 15 | |
| 14 | 2021 | 15 | |
| 15 | 2019 | 5 | |
| 16 | 2019 | 15 | |
| 17 | 2019 | 4 | |
| 18 | 2018 | 85 | |
| 19 | Possible Involvement of Pancreatic Fatty Infiltration in Pancreatic Carcinogenesis | 2016 | 3 |
| 20 | 2008 | 19 |
About Michihiro Mutoh
Michihiro Mutoh is a scholar working on Cancer Research, Pharmacology, Applied Microbiology and Biotechnology, Biotechnology and Oncology, having authored 168 papers that have together received 4.8k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (29 papers), Cancer, Lipids, and Metabolism (24 papers), Genetic factors in colorectal cancer (19 papers), Helicobacter pylori-related gastroenterology studies (14 papers), Pancreatic and Hepatic Oncology Research (13 papers), Gastric Cancer Management and Outcomes (13 papers), Cancer Research and Treatments (13 papers) and Seaweed-derived Bioactive Compounds (13 papers). The work is most often cited by research in Cancer Research (954 citations), Pharmacology (937 citations), Oncology (1.4k citations), Biotechnology (278 citations) and Biochemistry (191 citations). Michihiro Mutoh has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Mami Takahashi, Keiji Wakabayashi, Takashi Sügimura, Toshihiko Kawamori, Kazunori Fukuda, I Bae, Joany Jackman, Dominic A. Scudiero, Stephen Friend and Edward A. Sausville. Their work appears in journals such as Cancer Science, Journal of Clinical Biochemistry and Nutrition, Carcinogenesis, Genes and Environment and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.